Medtronic (MDT) Announces Quarterly Dividend of $0.71 per Share

Core Viewpoint - Medtronic plc (NYSE:MDT) is recognized as one of the 13 undervalued dividend aristocrats worth buying now [1]. Group 1: Company Overview - Medtronic develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally [2]. Group 2: Dividend Information - Medtronic declared a quarterly dividend of $0.71 per share on March 5, payable on April 17 to shareholders of record at the close of business on March 27, 2026 [3]. - The company has increased its annual dividend for the last 48 years, maintaining its status as a dividend aristocrat, with an annual dividend yield of 3.18% [3]. Group 3: Financial Performance - Medtronic reported better-than-expected results for Q3 2026, beating estimates in both earnings and revenue, with a 6% year-over-year organic revenue growth, the highest in ten quarters [4]. - The company aims for approximately 5.5% organic revenue growth for FY 2026 and maintains its adjusted EPS guidance in the range of $5.62 to $5.66 for the year [5].